<DOC>
	<DOCNO>NCT00580775</DOCNO>
	<brief_summary>As ancillary study KEEPS study ( see ClinicalTrials.gov Identifier : NCT00154180 ) , primary purpose measure effect estrogen vs. placebo menopausal woman , autonomic function repolarization ; measure non-invasively via holter monitoring .</brief_summary>
	<brief_title>Study Early Hormone Replacement Therapy Risk Factors Sudden Cardiac Death</brief_title>
	<detailed_description>The parent study KEEPS , randomize , placebo-controlled double blind , prospective trial two active group one placebo group . Only patient enrol KEEPS invited participate ancillary study.Duration KEEPS study 4 year randomization study subject , assessment primary endpoint , carotid CIMT , twice baseline , 12 , 24 , 36 48 month . Ancillary KEEPS study , patient undergo holter monitoring baseline , 24 48 months.Data analyze 24 48 month ( correspond data analysis primary endpoint . ) Holter monitor put schedule KEEPS visit , wear 24 hour return follow day . Effects estrogen heart rate variability ( HRV ) repolarization parameter evaluate , also correlate clinical , quality life , sleep mood information gather parent study . Anticipated enrollment parent study site 90 study subject . This ancillary involve use drug investigational device .</detailed_description>
	<mesh_term>Death</mesh_term>
	<mesh_term>Death , Sudden , Cardiac</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>participant KEEPS parent study : ClinicalTrials.gov Identifier NCT00154180 nonparticipant parent study</criteria>
	<gender>Female</gender>
	<minimum_age>42 Years</minimum_age>
	<maximum_age>58 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Menopause</keyword>
	<keyword>Hormone Replacement Therapy</keyword>
	<keyword>Sudden Cardiac Death</keyword>
</DOC>